Kohiki Taiki, Kato Yusuke, Nishikawa Yusuke, Yorita Kazuko, Sagawa Ikuko, Denda Masaya, Inokuma Tsubasa, Shigenaga Akira, Fukui Kiyoshi, Otaka Akira
Institute of Biomedical Sciences and Graduate School of Pharmaceutical Sciences, Tokushima University, Shomachi, Tokushima 770-8505, Japan.
Org Biomol Chem. 2017 Jun 27;15(25):5289-5297. doi: 10.1039/c7ob00633k.
Because of the relevance of d-serine (d-Ser) to schizophrenia, inhibitors of d-amino acid oxidase (DAO), which catalyzes degradation of d-Ser in the presence of flavin adenine dinucleotide (FAD), are expected to be anti-schizophrenia therapeutics. In this study, binding pockets of DAO to its inhibitor 4-bromo-3-nitrobenzoic acid were searched by combining in silico docking simulation and labeling experiments employing an N-sulfanylethylanilide-based labeling technology that we have developed. The results clearly demonstrated that there are two binding pockets: one is shared with d-Ser and FAD, and the other is an unexpected cleft between the subunits of a DAO dimer. These findings will provide insight to aid the development of new DAO inhibitors. In addition, it was also proved that our labeling technology could be applicable to elucidate the binding pockets of proteins.
由于D-丝氨酸(D-Ser)与精神分裂症相关,因此催化D-丝氨酸在黄素腺嘌呤二核苷酸(FAD)存在下发生降解的D-氨基酸氧化酶(DAO)抑制剂有望成为抗精神分裂症治疗药物。在本研究中,通过结合计算机对接模拟和使用我们开发的基于N-硫烷基乙苯胺的标记技术的标记实验,搜索了DAO与其抑制剂4-溴-3-硝基苯甲酸的结合口袋。结果清楚地表明存在两个结合口袋:一个与D-Ser和FAD共用,另一个是DAO二聚体亚基之间意外出现的裂缝。这些发现将为开发新的DAO抑制剂提供帮助。此外,还证明了我们的标记技术可用于阐明蛋白质的结合口袋。